Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 Study Group
Nom du journal : J Clin Oncol
Année : 2005
Volume : 23
Page de départ : 4265
Page de fin : 4274